304 related articles for article (PubMed ID: 30634453)
41. Co-Expression of Stem Cell and Epithelial Mesenchymal Transition Markers in Circulating Tumor Cells of Bladder Cancer Patients.
Zhang R; Xia J; Wang Y; Cao M; Jin D; Xue W; Huang Y; Chen H
Onco Targets Ther; 2020; 13():10739-10748. PubMed ID: 33122913
[TBL] [Abstract][Full Text] [Related]
42. Epithelial-mesenchymal transitioned circulating tumor cells capture for detecting tumor progression.
Satelli A; Mitra A; Brownlee Z; Xia X; Bellister S; Overman MJ; Kopetz S; Ellis LM; Meng QH; Li S
Clin Cancer Res; 2015 Feb; 21(4):899-906. PubMed ID: 25516888
[TBL] [Abstract][Full Text] [Related]
43. Epithelial-mesenchymal plasticity in circulating tumor cells.
Alix-Panabières C; Mader S; Pantel K
J Mol Med (Berl); 2017 Feb; 95(2):133-142. PubMed ID: 28013389
[TBL] [Abstract][Full Text] [Related]
44. Dynamic Monitoring of EMT in CTCs as an Indicator of Cancer Metastasis.
Zhang Z; Wuethrich A; Wang J; Korbie D; Lin LL; Trau M
Anal Chem; 2021 Dec; 93(50):16787-16795. PubMed ID: 34889595
[TBL] [Abstract][Full Text] [Related]
45. Mesenchymal phenotype of circulating tumor cells is associated with distant metastasis in breast cancer patients.
Zhang S; Wu T; Peng X; Liu J; Liu F; Wu S; Liu S; Dong Y; Xie S; Ma S
Cancer Manag Res; 2017; 9():691-700. PubMed ID: 29200889
[TBL] [Abstract][Full Text] [Related]
46. EMT status of circulating breast cancer cells and impact of fluidic shear stress.
Jin Y; Cai W; Zhao C; Yang F; Yang C; Zhang X; Zhou Q; Zhao W; Zhang C; Zhang F; Wang M; Li M
Exp Cell Res; 2022 Dec; 421(1):113385. PubMed ID: 36228736
[TBL] [Abstract][Full Text] [Related]
47. Circulating Tumor Cell Phenotype Indicates Poor Survival and Recurrence After Surgery for Hepatocellular Carcinoma.
Ou H; Huang Y; Xiang L; Chen Z; Fang Y; Lin Y; Cui Z; Yu S; Li X; Yang D
Dig Dis Sci; 2018 Sep; 63(9):2373-2380. PubMed ID: 29926241
[TBL] [Abstract][Full Text] [Related]
48. Prognostic Value of EMT-Circulating Tumor Cells in Metastatic Breast Cancer Patients Undergoing High-Dose Chemotherapy with Autologous Hematopoietic Stem Cell Transplantation.
Mego M; Gao H; Lee BN; Cohen EN; Tin S; Giordano A; Wu Q; Liu P; Nieto Y; Champlin RE; Hortobagyi GN; Cristofanilli M; Ueno NT; Reuben JM
J Cancer; 2012; 3():369-80. PubMed ID: 23074378
[TBL] [Abstract][Full Text] [Related]
49. Circulating Tumor Cells from Different Vascular Sites Exhibit Spatial Heterogeneity in Epithelial and Mesenchymal Composition and Distinct Clinical Significance in Hepatocellular Carcinoma.
Sun YF; Guo W; Xu Y; Shi YH; Gong ZJ; Ji Y; Du M; Zhang X; Hu B; Huang A; Chen GG; Lai PBS; Cao Y; Qiu SJ; Zhou J; Yang XR; Fan J
Clin Cancer Res; 2018 Feb; 24(3):547-559. PubMed ID: 29070526
[No Abstract] [Full Text] [Related]
50. Distinct expression of cytokeratin, N-cadherin and CD133 in circulating tumor cells of metastatic breast cancer patients.
Bock C; Rack B; Huober J; Andergassen U; Jeschke U; Doisneau-Sixou S
Future Oncol; 2014 Aug; 10(10):1751-65. PubMed ID: 25303055
[TBL] [Abstract][Full Text] [Related]
51. Epithelial-mesenchymal transition classification of circulating tumor cells in lung and colon cancer patients: potential role in clinical practice.
Fang J; Wang W; Fang J; Wang H; Lin L; Li F; Sun Q; Li F; Qi J; Sun X; Huo XX; Wang S; Wang H; Hong B; Deng Q; Nie J
Transl Cancer Res; 2020 Nov; 9(11):6639-6651. PubMed ID: 35117274
[TBL] [Abstract][Full Text] [Related]
52. Isolation of Viable Epithelial and Mesenchymal Circulating Tumor Cells from Breast Cancer Patients.
Topa J; Żaczek AJ; Markiewicz A
Methods Mol Biol; 2024; 2752():43-52. PubMed ID: 38194026
[TBL] [Abstract][Full Text] [Related]
53. An improved strategy to detect the epithelial-mesenchymal transition process in circulating tumor cells in hepatocellular carcinoma patients.
Liu YK; Hu BS; Li ZL; He X; Li Y; Lu LG
Hepatol Int; 2016 Jul; 10(4):640-6. PubMed ID: 27115761
[TBL] [Abstract][Full Text] [Related]
54. CTCs Expression Profiling for Advanced Breast Cancer Monitoring.
Pereira-Veiga T; Martínez-Fernández M; Abuin C; Piñeiro R; Cebey V; Cueva J; Palacios P; Blanco C; Muinelo-Romay L; Abalo A; Costa C; López-López R
Cancers (Basel); 2019 Dec; 11(12):. PubMed ID: 31817194
[TBL] [Abstract][Full Text] [Related]
55. Prognostic Significance of
Strati A; Nikolaou M; Georgoulias V; Lianidou ES
Cells; 2019 Jun; 8(7):. PubMed ID: 31261917
[TBL] [Abstract][Full Text] [Related]
56. Clinical Implication of Circulating Tumor Cells Expressing Epithelial Mesenchymal Transition (EMT) and Cancer Stem Cell (CSC) Markers and Their Perspective in HCC: A Systematic Review.
Orrapin S; Udomruk S; Lapisatepun W; Moonmuang S; Phanphaisarn A; Phinyo P; Pruksakorn D; Chaiyawat P
Cancers (Basel); 2022 Jul; 14(14):. PubMed ID: 35884432
[TBL] [Abstract][Full Text] [Related]
57. TROP2 is highly expressed in triple-negative breast cancer CTCs and is a potential marker for epithelial mesenchymal CTCs.
Liao Q; Zhang R; Ou Z; Ye Y; Zeng Q; Wang Y; Wang A; Chen T; Chai C; Guo B
Mol Ther Oncol; 2024 Mar; 32(1):200762. PubMed ID: 38596285
[TBL] [Abstract][Full Text] [Related]
58. Epithelial-mesenchymal transition increases during the progression of in situ to invasive basal-like breast cancer.
Choi Y; Lee HJ; Jang MH; Gwak JM; Lee KS; Kim EJ; Kim HJ; Lee HE; Park SY
Hum Pathol; 2013 Nov; 44(11):2581-9. PubMed ID: 24055090
[TBL] [Abstract][Full Text] [Related]
59. Mesenchymal-Epithelial Transition and Circulating Tumor Cells in Small Cell Lung Cancer.
Hamilton G; Rath B
Adv Exp Med Biol; 2017; 994():229-245. PubMed ID: 28560677
[TBL] [Abstract][Full Text] [Related]
60. Circulating Tumor Cells With Epithelial-to-mesenchymal Transition Phenotypes Associated With Inferior Outcomes in Primary Breast Cancer.
Mego M; Karaba M; Minarik G; Benca J; Silvia J; Sedlackova T; Manasova D; Kalavska K; Pindak D; Cristofanilli M; Reuben JM; Mardiak J
Anticancer Res; 2019 Apr; 39(4):1829-1837. PubMed ID: 30952723
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
